Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge

Insulin lispro 50/50 iu/ml

Levobupivacine 0.5 percent preservative free 20 ml inj

Running contract for inj.insulin glulisine (monocomponent insulin glulisine) with one free pen and 8 needle per 20 cartridges.

Inj human mixtard 50 50 pfs,insulin detemir 100iu inj,insulin highly purified isophane human nph 40iuml 10 ml inj,insulin biphasic isophane 30per soluble insulin and 70per isophane insulin human mixtard 30 70 inj,insulin lispro biphasic 25 75 25per insulin lispro and 75per insuline lispro protamine suspension 100iuml3ml humalog mix 25 3ml cartridge,insulin lispro biphasic 50per 50per insulin lispro and 50per insuline lispro protamine suspension 100iu ml 3ml cart humalog mix 50 3ml cart,insulin premixed biphasic human 50per human neutral 50 per human isophane insulin 10 ml inj,inj biphasic isophane insulin 30 human insulin 30 per as soluble insuline plus 70 per isophan insulin suspension 100iu 3 ml mixtard,inj biphasic isophane insulin 50 human insulin 50 per as soluble insuline plus 50 per isophan insulin suspension 100iuml mixtard 50 3 ml,inj insulin humalog lispro recombinan dna origin 100 iuml 3 ml,inj insulin lispro biphasic 50per insulin lispro 50per and insulin lispro protamine suspension 50 per 100 ium

Hq_med_drugs_gte_zrc_zonal rate contract for supply of [ph.no.10129] dulaglutide 1.5 mg/ 0.5 ml injection - prefilled pen

Levobupivacaine heavy 0.5 percent in 4 ml vial [levobupivacaine heavy 0.5 percent in 4 ml vial (0.5 percent heavy in 4 ml vial)]

Running contract for inj.tirzepatide 5 mg/0.6 ml in multidose prefilled pen,2.4 ml, 4 needles to be supplied with each pen at free of cost.

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

Proparacaine eye drop 0.5 percent 5 ml